Literature DB >> 11073866

Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors.

B L Lewis1, P O'Donnell.   

Abstract

The electrophysiological nature of dopamine actions has been controversial for years, with data supporting both inhibitory and excitatory actions. In this study, we tested whether stimulation of the ventral tegmental area (VTA), the source of the dopamine innervation of the prefrontal cortex, would exert different responses depending on the membrane potential states that pyramidal neurons exhibit when recorded in vivo, and whether VTA stimulation would have a role in controlling transitions between these states. Prefrontal cortical neurons have a very negative resting membrane potential (down state) interrupted by plateau depolarizations (up state). Although the up state had been shown to be dependent on hippocampal afferents in nucleus accumbens neurons, our results indicate that neither hippocampal nor thalamic inputs are sufficient to drive up events in prefrontal cortical neurons. Electrical VTA stimulation resulted in a variety of actions, in many cases depending on the neuron membrane potential state. Trains of stimuli resembling burst firing evoked a long-lasting transition to the up state, an effect blocked by a D(1) antagonist and mimicked by chemical VTA stimulation. These results indicate that projections from the VTA to the prefrontal cortex may be involved in controlling membrane potential states that define assemblies of activable pyramidal neurons in this region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073866     DOI: 10.1093/cercor/10.12.1168

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  106 in total

1.  The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior.

Authors:  K McFarland; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  Network synchrony in the nucleus accumbens in vivo.

Authors:  Y Goto; P O'Donnell
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

3.  Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

Authors:  Yukiori Goto; Patricio O'Donnell
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Interactions between frontal cortex and basal ganglia in working memory: a computational model.

Authors:  M J Frank; B Loughry; R C O'Reilly
Journal:  Cogn Affect Behav Neurosci       Date:  2001-06       Impact factor: 3.282

5.  Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures.

Authors:  Jeremy K Seamans; Lourdes Nogueira; Antonieta Lavin
Journal:  Cereb Cortex       Date:  2003-11       Impact factor: 5.357

6.  Repeated cocaine administration alters the electrophysiological properties of prefrontal cortical neurons.

Authors:  H Trantham; K K Szumlinski; K McFarland; P W Kalivas; A Lavin
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo.

Authors:  Anne Marie Brady; Patricio O'Donnell
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

8.  Acute cocaine administration depresses cortical activity.

Authors:  Heather Trantham-Davidson; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

9.  Burst generation in rat pyramidal neurones by regenerative potentials elicited in a restricted part of the basilar dendritic tree.

Authors:  Bogdan A Milojkovic; Mihailo S Radojicic; Patricia S Goldman-Rakic; Srdjan D Antic
Journal:  J Physiol       Date:  2004-05-21       Impact factor: 5.182

10.  Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

Authors:  Francesca Managò; Maddalena Mereu; Surjeet Mastwal; Rosa Mastrogiacomo; Diego Scheggia; Marco Emanuele; Maria A De Luca; Daniel R Weinberger; Kuan Hong Wang; Francesco Papaleo
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.